Co-Authors
This is a "connection" page, showing publications co-authored by Christopher Lehmann and Matthew Odenwald.
Connection Strength
0.520
-
Fecal metabolite profiling identifies liver transplant recipients at risk for postoperative infection. Cell Host Microbe. 2024 Jan 10; 32(1):117-130.e4.
Score: 0.234
-
Bifidobacteria metabolize lactulose to optimize gut metabolites and prevent systemic infection in patients with liver disease. Nat Microbiol. 2023 Nov; 8(11):2033-2049.
Score: 0.232
-
Immunomodulatory fecal metabolites are associated with mortality in COVID-19 patients with respiratory failure. Nat Commun. 2022 11 03; 13(1):6615.
Score: 0.054